About Sebia
Sebia is a Healthcare company based in Evry-courcouronnes (France) founded in 1967, and was acquired by CVC in October 2017. Electrophoresis-based in vitro diagnostics products are developed and provided. The company has 30 employees. Sebia has completed 2 acquisitions, including Orgentec Diagnostika and ZEUS Scientific. Its chief executive, as recorded, is Benoit Adelus. Its website sebia.com draws about 26 thousand monthly visits. Its Indian entity Sebia Diagnostics India Private Limited reported revenue of ₹64.26 Cr. Its focus areas include Diversified Diagnostics, Life Sciences, Clinical Genomics and Separation Based.
Company details
Sebia was founded in 1967 and is headquartered in Evry Courcouronnes, France. The company operates in the in vitro diagnostics sector, focusing on electrophoresis technologies. Solutions for capillary and gel electrophoresis are offered, along with integrated software packages. A test menu is provided for conditions including diabetes, hematological disorders, multiple myeloma, and alcoholism. Operations emphasize diagnostic tools for clinical applications.
- Headquarters Evry-courcouronnes, France
- Employees 30
- Stage Acquired
- SectorsHealthcare
- Website sebia.com
- Social LinkedIn YouTube
- Acquired by CVC (Oct 2017)
- Legal Name Sebia Diagnostics India Private Limited
- Date of Incorporation 26 Nov, 2019
- Jurisdiction Gurugram, Haryana, India
- Indian entity revenue₹64.26 Cr
FY 2025 · +16% YoY
- Indian entity net profit₹53.3 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹3.02 Cr
FY 2025 · 5% margin
- InvestorsCVC
& 5 more
- Employee Count30
- Investments & AcquisitionsOrgentec Diagnostika
& 1 more
- Acquired by
Associated legal entities of Sebia
Sebia operates through Sebia Diagnostics India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sebia Diagnostics India Private Limited CIN U85110HR2019FTC083840 | Active | 26 Nov 2019 | Gurugram, Haryana | ₹64.3 Cr | 30 | 4 | View details |
Apps and channels of Sebia
its YouTube channel SEBIA Group has 758 subscribers and 30 videos.
Videos from Sebia
The most watched videos on Sebia's YouTube channel, SEBIA Group (758 subscribers). Click a video to play it here.
More on SEBIA Group.
Funding Insights of Sebia
- Total Rounds 7
- Investors Count 3
All 7 funding rounds of Sebia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2026 | Unspecified | – | Warburg Pincus | – | |
| Jan 2023 | $19,279 | Grant | – | – | |
| Dec 2016 | $24,876 | Grant | – | – | |
| Jun 2015 | $28,172 | Grant | – | – | |
| Jun 2010 | Private Equity Round | – | – | ||
| Jun 2006 | Private Equity Round | – | – | ||
| Jun 2001 | Private Equity Round | – | – |
6 investors in total: 6 institutional.
Investors in Sebia
Sebia has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include CVC, European Union and Astorg.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Astorg is engaged in private equity investment management. | astorg.com | Paris, France | ||
Mezzanine financing and equity investments are provided by CVC. | 1981 | cvc.com | New York, United States | |
Private equity firm focused on energy, financial services, agriculture, and hospitality services | tethysinvestments.com | |||
Montagu Private Equity is engaged in mid-market business investments. | montagu.com | Frankfurt, Germany | ||
| warburgpincus.com | ||||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Sebia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Sebia Diagnostics India Private Limited (Sebia)
Sebia Diagnostics India Private Limited is the primary company behind Sebia. The board of Sebia Diagnostics India Private Limited currently have 4 directors; the longest-serving is Kamal Kishore Sharma, appointed in 2019. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kamal Kishore Sharma DIN 01585497 | Director | 26 Nov 2019 | 6 yrs 11 mo | Sebia Diagnostics India Private Limited |
| Vincent Dominique Gerard Verfaillie DIN 10335367 | Director | 30 Sep 2023 | 3 yrs 1 mo | Sebia Diagnostics India Private Limited |
| Rahul Aggarwal DIN 07945172 | Director | 30 Sep 2023 | 3 yrs 1 mo | Sebia Diagnostics India Private Limited |
| Guru Prasad Acharya DIN 10102628 | Director | 25 Jan 2024 | 2 yrs 9 mo | Sebia Diagnostics India Private Limited |
People of Sebia
30 people are tracked at Sebia (8 in leadership, 22 in team); the tracked headcount is 30.
| Name | Role | Group |
|---|---|---|
Benoit Adelus | Chairman & CEO | Leadership |
Cyrille Schreider | Vice President Global Marketing | Leadership |
Laurence Rouet | DRH Groupe / Vice President Human Resources Group | Leadership |
Jean-François Duflou | Marketing Director China | Leadership |
Pauline Fontaine | Director, MRD Business Development | Leadership |
Karen Anderson | Director Of Regulatory Affairs And Quality Assurance | Leadership |
Panagiotis Grypiotis | Global Marketing Director Autoimmunity | Leadership |
Thomas Lohmann | Director Medical Affairs | Leadership |
Filipa Varela | Scientific Affairs Manager | Team |
Brunhilde Dauphin | Responsable Qualité Projet Et Système | Team |
Shawn Cheong | Regional Marketing Manager, APAC | Team |
Grace Yongchua | Commercial Manager SEA And APAC Export | Team |
Claire Veretout | Compliance Manager | Team |
Nathalie Sassine | Group Marketing Manager | Team |
Julien Langlois | Responsable HRIS | Team |
Ella Duwattez | Ingénieure Affaires Réglementaires & Qualité - R&d | Team |
Pavel Poliak | Product Specialist / Application Specialist | Team |
Herman Boe | Group Marketing Manager | Team |
Olivier Bajzik | Global Manager | Team |
Andrew Owen | System Administrator | Team |
10 more people are available in the full profile.
Complete people profiles for Sebia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Sebia
Figures of Sebia Diagnostics India Private Limited, the primary company behind Sebia, for FY 2025. Revenue was ₹64.26 Cr (+16% year on year). Net profit was ₹53.3 Lakh (1% margin). EBITDA was ₹3.02 Cr (5% margin). Revenue has grown at a compounded annual rate of +20% over three years and +141% over five years.
- ₹64.26 CrRevenue · FY 2025 · +16% YoY
- ₹53.3 LakhNet profit · 1% margin
- ₹3.02 CrEBITDA · 5% margin
- ₹2.16 CrPaid-up capital
- 30Employees (provident fund records)
- +20%Revenue CAGR, 3 years
- +141%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sebia Diagnostics India Private Limited are on its company page.
Detailed financial statements for Sebia
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sebia
Sebia has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Orgentec Diagnostika and ZEUS Scientific.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
In vitro diagnostics for autoimmune and infectious diseases are provided. | zeusscientific.com | Branchburg, United States | 1976 | Oct 2022 | •••• | |
Diagnostics tools for Autoimmune and Infectious Diseases | orgentec.com | Mainz, Germany | 2009 | Jul 2020 | •••• |
Complete acquisition details for Sebia
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sebia
7 dated milestones of Sebia across 59 years, from founding to its latest funding, stage changes and deals.
- Founded Sebia is founded.
- Funding First funding round.
- Exit Acquired by Astorg Partners.
- Exit Acquired by CVC.
- Acquisition Acquires Orgentec Diagnostika.
- Acquisition Acquires ZEUS Scientific.
- Funding Latest funding round, Unspecified,.
Web traffic of Sebia
The website of Sebia (sebia.com) receives about 26.3K visits a month.
- Monthly visits26.3K
▼ 8.5% vs previous month
Websites whose visitors overlap most with Sebia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
akabaneheart-clinic.com | akabaneheart-clinic.com | 100% | #1,390,071 | – | |
codemap.com | codemap.com | 100% | #4,625,199 | – | |
bganalizadores.com.ar | bganalizadores.com.ar | 95% | – | ||
abbottdiagnostics.com | abbottdiagnostics.com | 95% | – | ||
| domzdravljabar.com | 83% | #9,558,222 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 26 similar websites and full traffic analytics for Sebia
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 26 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sebia
Complete news archive for Sebia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sebia
Sebia was founded in 1967 and raised its 1st funding round 34 years after it was founded.
Sebia is headquartered in Evry-courcouronnes, France. It is registered at Evry-courcouronnes, Essonne, France.
Benoit Adelus is the CEO of Sebia, as recorded in our data.
Sebia has 30 employees.
The primary company behind Sebia, Sebia Diagnostics India Private Limited, reported revenue of ₹64.26 Cr for FY 2025, up 16% year on year.
Sebia was founded in 1967 and is headquartered in Evry Courcouronnes, France. The company operates in the in vitro diagnostics sector, focusing on electrophoresis technologies. Solutions for capillary and gel electrophoresis are offered, along with integrated software packages. A test menu is provided for conditions including diabetes, hematological disorders, multiple myeloma, and alcoholism. Operations emphasize diagnostic tools for clinical applications.
Sebia has made 2 acquisitions, including Orgentec Diagnostika, and ZEUS Scientific.
Sebia has 6 investors. Key investors include CVC, European Union, Astorg, Tethys Investments, and Montagu Private Equity.
Sebia operates through Sebia Diagnostics India Private Limited.
Yes. Sebia was acquired by CVC in October 2017.
The legal entities of Sebia currently have 4 directors, including Vincent Dominique Gerard Verfaillie, Guru Prasad Acharya, Kamal Kishore Sharma and others.